Features List

CancerGene Connect, Breast Health Questionnaire and Patient Navigator tools are integrated to eliminate repetitive data entry.

CancerGene Connect Tool

Comprehensive patient and family history questionnaire covering the following topics:

  • Demographics - name, sex, birth date, address, ethnicity, etc.
  • OBGYN (female patients only) - period and pregnancy questions
  • Hormonal History (female patients only) - birth control and hormone treatment questions
  • Surgery - mammogram, breast surgery, hysterectomy, and oophorectomy questions
  • Colon - colonoscopy, polyps, colon surgery, and upper endoscopy questions
  • Health - medication, radiation, chemotherapy, and bone marrow transplant history
  • Lifestyle - height, weight, alcohol consumption, tobacco use, and exercise related questions
  • Psychological - depression, anxiety about cancer, social support related questions (validated assessment tool to alert providers)
  • Family Questionnaire - ages and cancer history of relatives (children, siblings, nieces/nephews, parents, aunts/uncles, cousins, and grandparents)
  • Pedigree - printable 3-generation pedigree (editable at any time by the provider)

Family Chart to track pending and resulted gene testing including mutations and variants for individual family members.

Risk assessment chart gives at a glance overview of the models running internally. All internal risk models can be viewed individually as well. 

  • Internal Models - Gail, Claus, Tyrer-Cuzick, BRCAPro, MelaPro, MMRpro and PancPro
  • External Links - PENN II, LAMBDA, Myriad Risk Tables, Cleveland Clinic PTEN Calculator, MMR Predict, NCI Colon Cancer Risk and PREMM

Customizable results letters, fact sheets, and best test letters with built-in macros to streamline the report writing process.

Database gives the ability to query reports filtered by any of the data points entered in the questionnaire - useful tool for both clinical research and administrative report generation.

Evaluate clinical productivity at a glance with 4 customizable dashboards. 

Breast Health Questionnaire Tool

Same comprehensive patient and family history questionnaire offered by the CancerGene Connect tool, tailored specifically to the breast health sphere:

  • Breast specific questions regarding reason for appointment
  • Additional surgery questions related to breast augmentation, breast reduction, weight loss, etc. 
  • Additional lifestyle questions including caffeine and soy consumption
  • Removal of the colon related questions

Family Chart to track pending and resulted gene testing including mutations and variants for individual family members.

Risk assessment chart gives at a glance overview of the models running internally. All internal risk models can be viewed individually as well. 

  • Internal Models - Gail, Claus, Tyrer-Cuzick, BRCAPro, MelaPro and PancPro
  • External Links - PENN II, LAMBDA, Myriad Risk Tables, and Cleveland Clinic PTEN Calculator

Track clinical metrics such as imaging reports, atypical findings, breast cancer, tumor markers, BI-RADS scores, and prognostic test results with the management tab.

Customizable results letters, fact sheets, and best test letters with built-in macros to streamline the report writing process.

Database gives the ability to query reports filtered by any of the data points entered in the questionnaire - useful tool for both clinical research and administrative report generation.

Evaluate clinical productivity at a glance with 4 customizable dashboards. 

Patient Navigator Tool

The Patient Navigator tool is used to quickly identify high risk individuals for genetic testing for hereditary breast cancer. 

  • Facilitate referrals to cancer genetics
  • Identify and track barrier to patient access and genetics services
  • Comprehensive follow-up tool allows providers to easily document and track prophylactic surgeries, surveillance, chemoprevention, and psychological support interventions for patients
  •  Identify patients at high lifetime risk for breast cancer that are optimal candidates for risk-reducing treatments such as breast MRI or tamoxifen